ENTRY       D11403                      Drug
NAME        Asciminib (USAN/INN)
FORMULA     C20H18ClF2N5O3
EXACT_MASS  449.1066
MOL_WEIGHT  449.8384
CLASS       Antineoplastic
             DG01918  Tyrosine kinase inhibitor
              DG03161  BCR-ABL inhibitor
            Metabolizing enzyme substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
             DG02924  UGT substrate
              DG03190  UGT2B7 substrate
              DG03181  UGT2B17 substrate
REMARK      ATC code: L01EA06
            Chemical structure group: DG03004
            Product (DG03004): D11404<JP/US>
EFFICACY    Antineoplastic, Tyrosine kinase inhibitor
TARGET      BCR-ABL [HSA:25] [KO:K06619]
  PATHWAY   hsa05200(25)  Pathways in cancer
METABOLISM  Enzyme: CYP3A4 [HSA:1576], UGT2B7 [HSA:7364], UGT2B17 [HSA:7367]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L01 ANTINEOPLASTIC AGENTS
               L01E PROTEIN KINASE INHIBITORS
                L01EA BCR-ABL tyrosine kinase inhibitors
                 L01EA06 Asciminib
                  D11403  Asciminib (USAN/INN)
            Drug groups [BR:br08330]
             Antineoplastic
              DG01918  Tyrosine kinase inhibitor
               DG03161  BCR-ABL inhibitor
                DG03004  Asciminib
                 D11403  Asciminib
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG03004  Asciminib
                 D11403  Asciminib
              DG02924  UGT substrate
               DG03190  UGT2B7 substrate
                DG03004  Asciminib
                 D11403  Asciminib
               DG03181  UGT2B17 substrate
                DG03004  Asciminib
                 D11403  Asciminib
            Target-based classification of drugs [BR:br08310]
             Protein kinases
              Non-receptor tyrosine kinases
               ABL family
                BCR-ABL
                 D11403  Asciminib (USAN/INN)
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D11403
            Drug groups [BR:br08330]
             Antineoplastic
              DG01918  Tyrosine kinase inhibitor
               DG03161  BCR-ABL inhibitor
                DG03004  Asciminib
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG03004  Asciminib
              DG02924  UGT substrate
               DG03190  UGT2B7 substrate
                DG03004  Asciminib
               DG03181  UGT2B17 substrate
                DG03004  Asciminib
DBLINKS     CAS: 1492952-76-7
            PubChem: 384585381
            PDB-CCD: AY7
ATOM        31
            1   C8y C    14.9605  -15.3802
            2   C8y C    14.9605  -16.7857
            3   C8x C    16.1776  -17.4884
            4   C8y C    17.3948  -16.7857
            5   C8x C    17.3948  -15.3802
            6   N5x N    16.1776  -14.6775
            7   N1y N    13.7435  -14.6744
            8   C1x C    13.7935  -13.2723
            9   C1x C    12.4756  -12.7914
            10  C1y C    11.6111  -13.8962
            11  C1x C    12.3946  -15.0600
            12  C8y C    13.7435  -17.4915
            13  N5x N    12.4121  -17.1107
            14  N4x N    11.6385  -18.2593
            15  C8x C    12.4918  -19.3500
            16  C8x C    13.7927  -18.8755
            17  O1a O    10.2029  -13.8460
            18  C5a C    18.6307  -17.4994
            19  N1b N    19.8406  -16.8010
            20  O5a O    18.6304  -18.8937
            21  C8y C    21.0275  -17.4865
            22  C8x C    21.0274  -18.8936
            23  C8x C    22.2445  -19.5965
            24  C8y C    23.4618  -18.8938
            25  C8x C    23.4619  -17.4867
            26  C8x C    22.2447  -16.7838
            27  O2a O    24.6801  -19.5975
            28  C1d C    25.8811  -18.9040
            29  X   Cl   27.0726  -19.5919
            30  X   F    26.5838  -17.6869
            31  X   F    25.1783  -17.6869
BOND        34
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     1   7 1
            8     7   8 1
            9     8   9 1
            10    9  10 1
            11   10  11 1
            12    7  11 1
            13    2  12 1
            14   12  13 2
            15   13  14 1
            16   14  15 1
            17   15  16 2
            18   12  16 1
            19   10  17 1 #Down
            20    4  18 1
            21   18  19 1
            22   18  20 2
            23   19  21 1
            24   21  22 2
            25   22  23 1
            26   23  24 2
            27   24  25 1
            28   25  26 2
            29   21  26 1
            30   24  27 1
            31   27  28 1
            32   28  29 1
            33   28  30 1
            34   28  31 1
///
